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Abstract 
Advances in metabolic engineering have led to the synthesis of a wide variety of valuable 
chemicals in microorganisms. The key to commercializing these processes is the improvement of 
titer, productivity, yield, and robustness. Traditional approaches to enhancing production uses 
the “push-pull-block” strategy that modulates enzyme expression under static control. However, 
strains are often optimized for specific laboratory set-up and are sensitive to environmental 
fluctuations. Exposure to sub-optimal growth conditions during large-scale fermentation often 
reduces their production capacity. Moreover, static control of engineered pathways may 
imbalance cofactors or cause the accumulation of toxic intermediates, which imposes burden on 
the host and results in decreased production. To overcome these problems, the last decade has 
witnessed the emergence of a new technology that uses synthetic regulation to control 
heterologous pathways dynamically, in ways akin to regulatory networks found in nature. Here 
we review natural metabolic control strategies and recent developments in how they inspire the 
engineering of dynamically regulated pathways. We further discuss the challenges of designing 
and engineering dynamic control and highlight how model-based design can provide a powerful 
formalism to engineer dynamic control circuits, which together with the tools of synthetic 
biology, can work to enhance microbial production. 
 
Keywords: Dynamic metabolic control, genetic circuits, biosensors, synthetic biology, model-
based design 
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§ 1. Introduction 
Microbial production of valuable chemicals provides an attractive alternative to petroleum-based 
synthesis routes. A wide variety of chemicals such as biofuels, pharmaceuticals, and 
nutraceuticals have been successfully produced in microbial hosts by assembling and optimizing 
metabolic pathways [71,47,48]. Typically, the expression of pathway enzymes is either 
constitutive or under the control of inducible promoters that are tuned to balance the pathway 
flux to maximize titers, productivities, and yields. Static overexpression of enzymes can impose 
a load onto the cell by competing for native resources from metabolism and draining resources 
such as ribosomes, ATPs and chaperones [23]. The extra load to the host cell also makes it 
challenging to dynamically balance resource allocation between cell growth and the engineered 
pathway. In addition, the obtained strains are often optimized under certain laboratory conditions 
and are not as robust in large bioreactors, where environmental fluctuations (e.g., nutrient 
concentration, temperature, dissolved oxygen, etc.) can subject cells to suboptimal conditions 
and lead to decreased production. Deviation from the optimal condition may divert carbon to 
byproducts or lead to the accumulation of toxic intermediates that attenuate cell growth [42]. 
Furthermore, engineered strains often suffer from stability issues where genetic mutations may 
arise during fermentation that deactivate the pathway activity. By comparison, natural cells 
maintain robust growth and withstand environmental fluctuations by dynamically adjusting 
cellular metabolism through complex regulatory networks. These regulatory networks govern the 
distribution of cellular resources and sustain homeostasis in fluctuating environments. 
The study of how natural regulatory networks enable cells to grow robustly has been a 
focus in systems biology. Diverse regulation mechanisms have been identified to dynamically 
control metabolism in response to varying environmental conditions and intracellular metabolic 
status [29,39,30,16]. These mechanisms sense environmental signals such as nutrient 
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concentration, pH, and light, as well as intracellular metabolite concentrations and cell density. 
The sensed signals are then coupled to transcriptional, translational or post-translational 
processes to control protein expression or activities for efficient carbon usage. Taking the 
concept of dynamic regulation, synthetic biologists have designed genetic circuits to dynamically 
regulate engineered pathways for optimal biochemical production [73,24,18,76,37,22,70,68]. 
In this review we discuss dynamic control strategies found in nature and how they inspire 
engineering efforts to increase bioproduction, with a particular focus on the design of control 
architectures. We further discuss some of the key challenges to designing dynamic control for 
enhancing biochemical production and highlight the utility of mathematical models to help 
address these. We conclude with an outlook that integrating design principles learned from 
natural control systems and model-based design into the metabolic engineering workflow can 
facilitate the design of dynamic metabolic control, towards the development of robust and 
efficient microbial cell factories. 
  
§ 2. Natural strategies for dynamic control of metabolism 
Dynamic regulation of metabolic pathways is ubiquitous in nature. Spanning from simple 
microbes to multicellular animals, all forms of life depend on complex regulatory networks to 
coordinate metabolism to maintain cellular activity and adapt to environmental changes. To 
achieve this, cells use a variety of strategies that involve the interplay between DNAs, RNAs, 
regulatory proteins, enzymes and metabolites. Transcriptional regulation represents a significant 
level of control that is responsive to a wide variety of molecules and exhibits versatile regulatory 
architectures. In Escherichia coli, 577 interactions have been identified between transcription 
factors and their regulated operons [55], and this number is still growing. These complex 
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interactions are made up of network motifs with different architectures that give rise to different 
functions [1].   
One major function of dynamic regulation is to allocate resources efficiently. This is 
mostly achieved by transcriptional control to avoid high cost of protein synthesis. At the 
transcriptional level, the expression of enzymes is often controlled by transcription factors that 
can sense either an intermediate or product of a pathway, generating different regulation 
architectures. For example, in the lysine biosynthesis pathway in Saccharomyces cerevisiae, the 
transcription factor Lys14 is activated by an intermediate alpha aminoadipate 6-semialdehyde 
(αAAS), which activates all the seven genes in the pathway. Similarly, enzymes in the arginine 
biosynthesis pathway of E. coli are repressed by ArgR, which is in turn activated by the end 
product arginine. Experimental analyses and cost-benefit models for enzyme expression have 
uncovered links between regulatory architecture and the timing of gene expression in unbranched 
pathways [44,15,72,17], revealing unique patterns of timing and promoter activity for efficient 
enzyme expression. 
In addition to the transcriptional level, many cellular activities are modulated at the 
translational and post-translational levels, and oftentimes interplay among them. Translational 
regulation, usually through controlling translation initiation rate or mRNA stability, only respond 
to a small number of metabolites due to the limited chemical diversity of nucleic acids. Post 
translational regulation is abundant in metabolic pathways and controls enzyme activities in 
response to environmental stimuli or metabolite concentrations. For example, enzymes in E. coli 
central metabolism are heavily regulated at the post-translational level to tightly maintain 
constant metabolic flux under small environmental perturbations [50]. In addition, product 
allosteric inhibition of the first enzyme in metabolic pathways is commonly observed to rapidly 
turn down the metabolic flux through the pathway, allowing for immediate saving on carbon 
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usage. By comparison, transcriptional or translational regulation, though responding at a slower 
time scale due to slow protein synthesis and dilution, can drastically shift the distribution of 
metabolic flux and enable cells to save resources in the long run. Among different levels of 
regulation, transcriptional regulation offers a variety of traits desirable for engineering 
applications, including versatility in regulation architecture, chemical diversity of the sensed 
molecules, and tunability of the regulatory parameters. Indeed, transcriptional regulation is the 
most widely used control in metabolic engineering. Overall, understanding natural regulatory 
mechanisms provides us a wide variety of tools and design principles to develop synthetic 
dynamic control, which can be applied in metabolic engineering [36].  
 
§ 3. Engineered strategies for dynamic control of metabolism 
A synthetic dynamic control circuit typically consists of a biosensor and a genetic 
controller. The application of biosensors [75,39,35,74] and genetic control circuits [58,10] have 
been extensively reviewed. A variety of signals can be detected to sense cellular growth status or 
a change in the environment, such as intracellular metabolites, quorum signal molecules (AHLs), 
exogenous stimuli (inducers and lights), and environmental signals (pH, oxygen, and 
temperature). These signals can be used to repress or activate enzyme expression and thus 
regulate flux of a pathway. One primary design objective for dynamic control of metabolic flux 
is to balance the growth of the cell and production of the target molecule. Next, we discuss 
different types of design strategies from input signals to output regulations that attempt to 
address this objective. 
The basic method to dynamically regulate the flux distribution is adding exogenous 
inducers or nutrients at a time point during fermentation (Fig. 1a). Xie et al. constructed a 
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glucose-dependent regulatory system in S. cerevisiae to control the flux from branch point 
farnesyl diphosphate (FPP) to ergosterol biosynthesis (an essential component in yeast 
membrane) or to the carotenoid pathway [69]. Squalene synthase (erg9), the first gene from FPP 
to ergosterol pathway, was placed under the HXT1 promoter, which was induced at high glucose 
concentration, while the carotenoid pathway was controlled by glucose-repressible GAL 
promoters so that the production pathway was turned on after glucose was partially replaced by 
glycerol as an alternative carbon source. Dynamic regulation by exogenous inducers is 
straightforward and effective, but is expensive, can cost the environment and required manual 
intervention. These problems can be overcome by introducing feedback control of enzyme 
expression to respond to signals produced by the cell itself. 
An example of autonomous control is that on growth flux through negative feedback by a 
quorum sensing (QS) system (Fig. 1b). Soma and Hanai employed a QS system to autonomously 
redirect acetyl-CoA from the TCA cycle to the isopropanol pathway at a given cell density [60]. 
In a recent application, QS was used to downregulate phosphofructokinase-1 (pfk-1) in the upper 
glycolysis pathway [24]. Lower pfk-1 activity channeled more carbon flux from the 
interconverting branch points G6P and F6P to the glucaric acid pathway, thus turning on product 
synthesis while inhibiting cell growth.  
One key function of dynamic control in a biosynthetic pathway is to avoid accumulation 
of toxic intermediates or overexpression of toxic enzymes. Inhibiting an upstream pathway that 
generates the toxic intermediate and activating a downstream pathway that converts it are 
common control strategies (Fig. 1c). One of the pioneering works in dynamic pathway regulation 
was demonstrated for biodiesel production from free fatty acids [73]. In the pathway, 
accumulation of two intermediates ethanol and acyl-CoA is harmful to cell growth. The authors 
developed a dynamic regulatory system to activate ethanol production and the conversion of 
8 
ethanol and acyl-CoAs to final products only when fatty acyl-CoAs are sufficient. In another 
example, promoters responsive to FPP (toxic to cell) accumulation were used to repress the 
mevalonate pathway that produces FPP and to activate amorphadiene synthase that consumes 
FPP. Such regulatory topology dynamically stabilized the FPP concentration below its toxic 
level, while increasing amorphadiene production [18]. Similar control topologies can be 
constructed using transcription-factor-based sensors as demonstrated in the fatty acid pathway to 
optimize cellular malonyl-CoA pool [70]. In addition, synthetic inverters can be used to switch 
regulation between repression and activation, achieving a desired control topology [37].  
Dynamic regulation can also be designed by sensing signals to indicate growth status and 
using them to regulate metabolite production. In one of the first examples of dynamic regulation, 
acetyl phosphate served as the signal for excess glycolytic flux to regulate the rate-limiting 
enzymes in lycopene pathway [22] (Fig. 1d). Recently, a biosynthetic pathway was controlled by 
a two-layered circuit, which acted as an AND gate that senses both the cellular growth status and 
the pathway precursor availability [38]. The first enzymatic step was not turned on until 
stationary phase and downstream steps were activated by the intermediate from the first step 
(Fig. 1e), which reduces burden from the engineered metabolic pathway. Synthetic control can 
also be designed to sense production flux and regulate growth (Fig. 1f). Xiao et al. described a 
strategy that uses metabolite product to activate cell growth via expression of an antibiotic pump, 
TetA [68]. This ensured that high producing cells would tolerate the antibiotic treatment, and 
thus facilitated the selection of high producing phenotypes at the population level. Without 
selection, a wide variation in biosynthetic performance was observed in the whole population. 
With selection, only the high-performing cells could survive, thus increasing total production.  
Despite a growing number of success stories, engineering dynamic control remains 
extremely challenging. Current implementations require multiple iterations between construction 
9 
of part libraries, testing of different control architectures, and characterization of system 
performance. This lengthy design cycle is the result of multiple challenges that need to be 
addressed if the field is to move towards precision engineering of metabolism.  
 
§ 4. Challenges for dynamic control and benefits of model-based design. 
The capability to precisely control metabolism is key to optimizing complex and 
dynamic bioprocesses, and many challenges lie at different levels to apply dynamic control 
at an industrial scale. In large fermenters the level of intracellular metabolites and the 
environmental conditions can vary dramatically under different fermentation conditions. 
In addition, biosensors that work in model organisms may not function in an industrial 
host simply because the sensor is out of range. Therefore it is crucial to tune the parts to 
ensure the functioning of the dynamic control.  The number of possible dynamic control 
design architectures can also be quite large, with a choice of what to sense, which 
enzymatic steps to regulate, and how to control enzyme expression levels 
(activation/repression). In the combinatorial explosion of possible designs, it is extremely 
difficult to experimentally determine the optimal design to give maximum, robust 
production, with minimum attenuation to cell growth demands. In addition, in large 
fermenters the difference in the time scale of heat and mass transfer also poses the 
challenge of how to tune dynamic control to match the magnitude and timescale of such 
environmental changes. Third, the control circuits need to function robustly within a host 
during long periods of fermentation. Thus, a good understanding of the host-circuit 
interaction is needed to account for resource allocation in the host. Lastly, in large 
bioreactors there are often increased cell-to-cell variations, and the challenge is how to 
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control the product distribution to shift the population to achieve higher percentage of 
high-producers. 
In summary, current challenges for dynamic control include the construction and tuning 
of genetic parts, the assembly of parts into functional circuits, the interplay between circuit and 
host, and the control of population diversity (Fig. 2). Mathematical modelling is an ideal 
framework to integrate different design layers and explore the design space in a rational manner. 
Next, we discuss some of the key challenges ahead and outline how modelling can help 
overcome them.  
 
§ 4.1. Construction of tunable parts 
Metabolite biosensors are a key component of dynamic metabolic control. Their function 
is to control the expression of pathway enzymes in response to metabolic signals such as the 
concentrations of metabolic intermediates or other physicochemical cues. Bioproduction growth 
conditions may shift signal concentrations to ranges that fall beyond the biosensor inducing 
threshold, impairing dynamic control and resulting in a effective static setting. It is therefore 
essential to be able to design and tune biosensor function to ensure its successful application, 
especially in industrially relevant conditions. In particular, biosensor function need to be 
designed to respond with the appropriate sensitivity, such as an all-or-none or graded response, 
cover a broad response dynamic range, and to reliably sense signal concentration and actuate the 
response at the right signal threshold, as appropriate for the growth conditions. Biosensor 
function can be captured in the dose-response curve, which relates the concentration of the 
sensed metabolite to the enzyme expression (Fig. 2) and its shape can be modified through 
experimentally tunable parameters such as the metabolite binding affinity [Saeki et al (2015)] or 
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the sequence of target promoters [40]. Some of the successful implementations of dynamic 
control have demonstrated that tuning the biosensor dose-response curve can affect performance 
significantly and increase production [37,70,68]. The question of how to design dynamic control 
is thus critical to developing production strains, especially for application in industrial settings. 
Much work has focused on developing new biosensors, but the precise calibration of their dose-
response curve remains poorly understood [3] and leads to lengthy iterations between biosensor 
construction and characterization. 
Common biosensors in dynamic control are transcriptional riboswitches [7] and 
transcription factors [75]. Progress in RNA engineering has led to a growing number of 
riboswitches that respond to specific metabolites [66,26]. Studies have shown that RNA 
sequences shape the sensitivity and threshold of riboswitch dose-response curves [52,5], yet the 
precise tuning of riboswitch function remains a significant challenge. Computational methods 
have proven powerful for the design of RNA devices [13] and mathematical modelling has 
revealed insights on the tunability of the riboswitch function in terms of biophysical parameters 
[6]. Integration of sequence design algorithms with mathematical models may facilitate the 
discovery of new metabolite-responsive riboswitches, and thus expand the repertoire of pathways 
in which dynamic control can be used [7]. 
In the case of transcription factors, dose-response curves can be tuned with promoter 
engineering [40] or protein engineering to modify metabolite binding kinetics [Saeki et al 
(2015),63]. There are many natural transcription factors that respond to specific metabolites in 
their native host, which can be repurposed as biosensors in a production host of interest. Detailed 
biophysical models have revealed relations between sequence-dependent promoter binding 
affinities and protein expression [9]. Moreover, mathematical models have uncovered 
fundamental design constraints of dose-response curves, and together with experimental 
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validation, revealed a strategy for orthogonal control of biosensor dynamic range and threshold 
[40], an essential criteria for free design of biosensor function, and in turn real-world application. 
§ 4.2. Assembling parts to design control circuits 
Tunable parts provide the fundamental building block for the assembly of control circuits 
that will help to achieve an increased and robust production. Dynamic control circuits must 
achieve multiple design objectives simultaneously [46], where the goal is to construct control 
circuits that adapt pathway activity to varying bioreactor conditions, ensuring efficient 
expression of enzymes, minimizing the impact of pathway bottlenecks or accumulation of toxic 
intermediates, and ultimately maximize biochemical yield, titer or flux rate for economically 
viable production at industrial scales. Achieving all these objectives demands the availability of a 
wide repertoire of control circuit architectures, and the problem is the freedom in designing the 
architecture. In reality, architecture design is severely constrained by what can be sensed and the 
nature of the interaction between the metabolite-biosensor and biosensor-DNA (inhibitory or 
activatory) [75]. A metabolite that is indicative of the shift in condition and can be sensed is 
chosen, but its position, whether it is an end product or intermediate of the production pathway, 
can constrain the nature of the control [17]. Moreover, the choice of transcription factor sensing 
the chosen metabolite signal may not function as a dual regulator, only activating or inhibiting 
gene expression, further constraining the control design space. Key questions for architecture 
design thus are which pathway metabolite should be sensed, which enzymatic steps to implement 
dynamic control on and the nature of the controls (inhibit or activate enzyme expression). 
Mathematical modelling can be a powerful tool to explore such design space and assess 
performance of architectures that would otherwise be infeasible or too costly to test 
experimentally. 
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Unlike in static control, where genome-scale models can be used for strain design 
[11,57], model-based approaches for dynamic control are still in early stages. Mathematical 
models have revealed design principles to improve biofuel production through control of efflux 
pumps [21] and have provided conditions on the parameter design space to avoid accumulation 
of toxic intermediates [46]. Genome-scale models have been employed to determine which 
enzymes to control, which when coupled with dynamic modelling showed higher production as 
compared to static control [2]. A particularly promising use for modelling is the exploration of 
circuit architectures. Models have been used to search for architectures that efficiently trade-off 
production flux against toxicity effects by metabolic intermediates [61], to explore circuit 
architectures that function robustly in the face of environmental or genetic perturbations [25], or 
to discover new useful architectures, such as a bistable metabolic switch that filters out 
fluctuations in nutrient availability [43]. 
Control engineering has been tremendously successful in designing regulation systems 
for diverse disciplines such as aerospace, bioprocessing, and information technologies [4]. 
Principles from control engineering have gained ground in synthetic biology [19] and optimal 
control ideas have revealed design principles in natural metabolic systems [65,72], but their 
broader application to dynamic pathway control remains less explored. A potential area for 
future development is the use of mathematical optimization for circuit design [53] coupled with 
detailed kinetic models of metabolism [32,49,41,14,27] to maximize production (yield, titer or 
product flux rate). The optimization of control can be programmed to scan over circuit 
architecture and parameters simultaneously, but for increases in the control circuit detail and size 
exploration of the design space is quickly plagued by the curse of dimensionality. The trade-off 
between circuit size and computation time needs to be considered, and the development of more 
scalable optimization methods poses a challenge and opportunity for further research. 
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§ 4.3. Host-circuit interactions 
As metabolic pathways and control circuits become larger and more complex, their 
footprint on their host can become a major limiting factor on function. Engineered systems draw 
resources from the host, which can disrupt homeostasis and cause growth defects that lead to 
poor or even altered functionality [62,12]. A key source for host-circuit interactions is the 
competition for cellular resources such as ribosomes, RNA polymerases, and amino acid pools 
[8]. This competition affects cell growth and ultimately may result in an impaired circuit 
function, and in turn make for a suboptimal metabolic production that is economically 
impracticable for industrial level production. 
Mathematical models can give a systems-level understanding of the relationship between 
circuit function and the physiology of the host where they reside. To this end, Weiße and 
colleagues developed a mechanistic model for bacterial growth, based on a coarse-grained 
partition of the proteome and its interaction through metabolism, transcription and translation 
[67]. The model predicts growth defects caused by gene circuits and provides a quantitative 
platform to assess the impact of growth defects on circuit function. A recent extension to this 
work includes more detailed mechanisms of the different host-circuit crosstalks and proved 
useful for circuit design [34]. Models for host-circuit interactions do not yet allow the inclusion 
of dynamic pathway control, but the use of dynamic control to manage host load and increase 
production is promising, especially in light of recent evidence showing that feedback control can 
mitigate the impact of resource coupling [56].  
§ 4.4. Control of population heterogeneity 
Phenotypic heterogeneity is ubiquitous in cellular populations. In microbes, heterogeneity 
has been extensively studied as a product of stochasticity in gene expression and the resulting 
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variation in protein levels [51], and recent work has focused on variability on metabolic 
phenotypes and growth [59,31,28]. Though phenotypic variability in natural systems can serve as 
a population survival strategy, variability amongst strains engineered for production can lead to 
suboptimal performance. Phenotypic variability may also result from fluctuations in growth 
conditions, and in scaling-up to industrial level production inhomogeneities in growth media can 
become exaggerated. In strains engineered for chemical production, phenotypic variability 
manifests itself as wide distributions of metabolic production [54,20]. Such variability has been 
exploited to increase production by designing control that couples the concentration of product to 
growth, and thereby selects for high producers [68]. 
Mathematical modelling can provide novel insights on the sources and control of 
metabolic variability. For example, the integration of genome-scale models with single-cell 
proteomics datasets revealed the emergence of a bimodal growth distribution in E. coli [33], and 
the emergence of bimodal phenotypes was also explored with dynamic models [64,31]. A 
seminal stochastic modelling work on enzymatic reactions revealed conditions for a dynamic 
control circuit to amplify or attenuate the variability of a metabolic product [45]. 
It is worth noting that the emergence of mutants and genotypic heterogeneity pose a 
significant problem for long term biochemical production, and can plague the implementation of 
production strains at industrial scales. Over long time scales of fermentation mutations may 
impair the control circuit or result in the emergence of non-producing, faster growing strains that 
will dilute out production strains. Though there is some understanding that very low expression 
of DNA repair mechanisms, such as demethylation by N-Ada protein, can lead to the emergence 
of genotypic heterogeneity [(Uphoff et al (2016))], it is unclear how to control for it. This is a 
key area for future development to help sustain long-term bioproduction in industrial settings. 
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§ 5. Final remarks 
Dynamic control of metabolism is a powerful mechanism for cells to survive and adapt to 
environmental perturbations. In natural systems, dynamic control shifts metabolic activity 
between various operating regimes. Metabolic engineering can harness similar control strategies 
to increase production in varying and often unpredictable bioreactor conditions. In this paper we 
outlined some of the natural strategies for dynamic control together with recent successful 
implementations on metabolic production pathways.  
Dynamic control has vast potential to enhance production at the industrial scale, enabling 
autonomous control of pathway activity without the cost of inducers and auto-adapting 
production and cellular demands according to fluctuating or changing fermentation conditions. 
Challenges for this technology are manifold and cover several layers of complexity, from tunable 
control parts, to functional circuits, accounting for host physiology and demands of the cell, and 
sustaining production in the face of phenotypic and emergence of genotypic heterogeneity. In 
this paper we discussed the challenges at these levels and how they affect the application of 
strains engineered with dynamic control to industrial scale bioproduction. Although a few recent 
studies have demonstrated the computation-guided tuning of biosensor response, the reliable 
determination of the intracellular metabolite concentration remains a challenge to providing 
accurate inputs to the model. In addition, the application of dynamic control in industrially 
relevant hosts has been limited, which entails tools and efforts to transfer the technology into 
those hosts (cite lysine paper). Robust controls need to use the host resources efficiently and 
optimize the balance between growth and production. This is a challenging objective to achieve, 
and one where the metabolic engineering community can learn valuable lessons from natural 
systems. Systems biology has revealed fundamental design principles by reverse-engineering the 
regulation of natural metabolic systems, thanks to the combination of mathematical modelling 
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and wet-lab experimentation. Natural design principles and model-based methods integrated into 
the metabolic engineering workflow could institute the forward-engineering of control circuits 
and hail a new era in which dynamic control becomes the key technology for optimizing 
chemical production. 
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Figure 1. Engineered control strategies of metabolic pathway in bioproduction. To abstract 
the designs of different dynamic control strategies, we represent cell growth and product 
biosynthesis as two linear fluxes that branch from the same precursor metabolite, where growth 
encompasses fluxes towards essential metabolites (e.g. TCA cycle, amino acid biosynthesis, 
nucleotide biosynthesis, membrane biosynthesis). (a) Using inducers to control flux from the 
branch point [69]. (b) Using QS systems to control growth flux by negative feedback circuits 
[24,60]. (c) Using metabolite-responsive regulators to control toxic intermediate levels 
[73,18,37,70]. (d) Using growth flux to activate the production pathway [22]. (e) Using 
metabolite levels and growth status, which accounts for toxic effects, to regulate the production 
pathway [38]. (f) Using product level to control survival of the cells [68]. 
 
Figure 2. Challenges for designing dynamic control circuits at various levels. These 
challenges include how to tune parts to obtain desired dose-response functions, when control is 
actuated by riboswitches [6,52] or transcription factors [40,63]; how regulatory architectures 
affect dynamics [17,46,61] and robustness [43], as learned from models of natural control 
systems; how to balance limited resources between growth and production, studied theoretically 
26 
[34,67]; and how to control cell-cell heterogeneity for sustainable and efficient production, 
studied theoretically [45] and experimentally [68]. 
